跳至主要内容
临床试验/ITMCTR2000003276
ITMCTR2000003276尚未招募1 期

The effect of Sancai powder on glycemic variability of type 2 diabetes in the elderly: a randomized controlled trial.

The Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
65 至 85(—)
性别
All

入选标准

  • (1) Participants are 65-85 years old.
  • (2) Meet the diagnostic criteria for type 2 diabetes.
  • (3) The BMI is between 18 kg / m2 and 28 kg / m2.
  • (4) Blood biochemical indicators such as liver and kidney function are normal.
  • (5) Accept and sign the informed consent.

排除标准

  • (1) Glycated hemoglobin is greater than 10%.
  • (2) Diabetes is in the period of acute complications, such as diabetic ketoacidosis, diabetic hyperosmolar nonketotic coma, hypoglycemic coma or severe unconscious hypoglycemia.
  • (3) Diabetic patients with severe chronic complications, such as diabetic foot with infection, diabetic nephropathy with renal insufficiency, diabetic retinopathy of more than 3 stages, etc.
  • (4) Patients with anxiety, depression, mania, or other mental illness.
  • (5)Patients with a history of stroke, transient ischemic attack, unstable angina, and myocardial infarction in the first 6 months of the study were patients with congestive heart failure.
  • (6) A history of acute or chronic pancreatitis.
  • (7) Allergic to Chinese herbal medicine.
  • (8) The history of the use of immunosuppressants and glucocorticoids in the past three months.
  • (9) Involuntary ability and other diseases affecting glucose metabolism.
  • (10) Patients who were enrolled in other clinical tests in the past three months.

研究者

发起方
The Hospital of Chengdu University of Traditional Chinese Medicine

相似试验